A Low Dietary Ratio of Omega-6 to Omega-3 Fatty Acids May Delay Progression of Prostate Cancer

REFERENCES

• Jemal , A , Siegel , R , Xu , J and Ward , E . 2010 . Cancer Statistics, 2010 . CA Cancer J Clin , 60 : 277 – 300 .
   PubMed Web of Science ®Google Scholar
• Brawley , O W . 2012 . Prostate cancer epidemiology in the United States . World J Urol , 30 : 195 – 200 .
   PubMed Web of Science ®Google Scholar
• Harris , W P , Mostaghel , E A , Nelson , P S and Montomery , B . 2009 . Androgen deprivation therapy: progress in understanding mechanisms of resistance and optimizing androgen depletion . Nat Clin Pract Urol , 6 : 76 – 85 .
   PubMedGoogle Scholar
• Suzuki , H , Kamiya , N , Imamoto , T , Kawamura , K Yano , M . 2008 . Current topics and perspectives relating to hormone therapy for prostate cancer . Int J Clin Oncol , 3 : 401 – 410 .
   Web of Science ®Google Scholar
• Higano , C S . 2003 . Side effects of androgen deprivation therapy: monitoring and minimizing toxicity . Urology , 61 ( 2A ) : 32 – 38 . Suppl
   PubMed Web of Science ®Google Scholar
• Sharifi , N , Gulley , J L and Dahut , W L . 2005 . Androgen deprivation therapy for prostate cancer . JAMA , 294 : 238 – 244 .
   PubMed Web of Science ®Google Scholar
• Baade , P D , Youlden , D R and Krnjacki , L J . 2009 . International epidemiology of prostate cancer: Geographical distribution and secular trends . Mol Nutr Food Res , 53 : 171 – 184 .
   PubMed Web of Science ®Google Scholar
• Marugame , T and Katanoda , K . 2006 . International comparisons of cumulative risk of breast and prostate cancer, from cancer incidence in five continents: Vol. 8 . Jpn J Clin Oncol , 36 : 399 – 400 .
   PubMed Web of Science ®Google Scholar
• Rodriguez , C , McCullough , M L , Mondul , A M , Jacobs , E J Chao , A . 2006 . Meat consumption among black and white men and risk of prostate cancer in the Cancer Prevention Study II Nutrition Cohort . Cancer Epidemiol Biomarkers Prev , 15 : 211 – 216 .
   PubMed Web of Science ®Google Scholar
• Walker , M , Aronson , K J , King , W , Wilson , W JL Fan , W . 2005 . Dietary patterns and risk of prostate cancer in Ontario, Canada . Int J Cancer , 116 : 592 – 598 .
   PubMed Web of Science ®Google Scholar
• Ritch , C R , Wan , R L , Stephens , L B , Taxy , J B Huo , D . 2007 . Dietary fatty acids correlate with prostate cancer biopsy grade and volume in Jamaican men . J Urol , 177 : 97 – 101 .
   PubMed Web of Science ®Google Scholar
• Simopoulos , A P . 2008 . The importance of the omega-6/omega-3 fatty acid ratio in cardiovascular disease and other chronic diseases . Exp Biol Med , 233 : 674 – 688 .
   PubMed Web of Science ®Google Scholar
• Simopoulos , A P . 2006 . Evolutionary aspects of diet, the omega-6/omega-3 ratio and genetic variation: nutritional implications for chronic diseases . Biomed Pharmacother , 60 : 502 – 507 .
   PubMed Web of Science ®Google Scholar
• Hsing , A W , Tsao , L and Devesa , S S . 2000 . International trends and patterns of prostate cancer incidence and mortality . Int J Cancer , 85 : 60 – 67 .
   PubMed Web of Science ®Google Scholar
• Leitzmann , M F , Stampfer , M J , Michaud , D S , Augustsson , K Colditz , G A . 2004 . Dietary intake of omega-3 and omega-6 fatty acids and the risk of prostate cancer . Am J Clin Nutr , 80 : 204 – 216 .
   PubMed Web of Science ®Google Scholar
• Szymanski , K M , Wheeler , D C and Mucci , L A . 2010 . Fish consumption and prostate cancer risk: a review and meta-analysis . Am J Clin Nutr , 92 : 1223 – 1233 .
   PubMed Web of Science ®Google Scholar
• Chavarro , J E , Stampfer , M J , Li , H , Campos , H Kurth , T . 2007 . A prospective study of polyunsaturated fatty acid levels in blood and prostate cancer risk . Cancer Epidemiol Biomarkers Prev , 16 : 1364 – 1370 .
   PubMed Web of Science ®Google Scholar
• Hu , Y , Sun , H , Owens , R T , Gu , Z Wu , J . 2010 . Syndecan-1-dependent suppression of PDK1/Akt/bad signaling by docosahexaenoic acid induces apoptosis in prostate cancer . Neoplasia , 12 : 826 – 836 .
   PubMed Web of Science ®Google Scholar
• Akinsete , J A , Ion , G , Witte , T R and Hardman , W E . 2012 . Consumption of high v-3 fatty acid diet suppressed prostate tumorigenesis in C3(1) Tag mice . Carcinogenesis , 33 : 140 – 148 .
   PubMed Web of Science ®Google Scholar
• Connolly , J M , Coleman , M and Rose , D P . 1997 . Effects of dietary fatty acids on DU145 human prostate cancer cell growth in athymic nude mice . Nutr Cancer , 29 : 114 – 119 .
   PubMed Web of Science ®Google Scholar
• Hughes-Fulford , M , Li , CF , Boonyaratanakornkit , J and Sayyah , S . 2006 . Arachidonic acid activates phosphatidylinositol 3-kinase signaling and induces gene expression in prostate cancer . Cancer Res , 66 : 1427 – 1433 .
   PubMed Web of Science ®Google Scholar
• Ghosh , J and Myers , C E . 1997 . Arachidonic acid stimulates prostate cancer cell growth: critical role of 5-lipoxygenase . Biochem Biophys Res Comm , 235 : 418 – 423 .
   PubMed Web of Science ®Google Scholar
• Gomez , S L , Le , G M , Clarke , C A , Glaser , S L France , A . 2003 . Cancer incidence patterns in Koreans in the US and in Kangwha, South Korea . Cancer Causes Control , 14 : 167 – 174 .
   PubMed Web of Science ®Google Scholar
• Shimizu , H , Ross , R K , Bernstein , L , Yatani , R , Henderson , B E and Mack , T M . 1991 . Cancers of the prostate and breast among Japanese and white immigrants in Los Angeles County . Br J Cancer , 63 : 963 – 966 .
   PubMed Web of Science ®Google Scholar
• Lee , J , Demissie , K , Lu , S-E and Rhoads , G G . 2007 . Cancer incidence among Korean-American immigrants in the United States and native Koreans in South Korea . Cancer Control , 14 : 78 – 85 .
   PubMedGoogle Scholar
• Mamalakis , G , Kafatos , A , Kalogeropoulos , N , Andrikopoulos , N Daskalopulos , G . 2002 . Prostate cancer vs hyperplasia: relationships with prostatic and adipose tissue fatty acid composition . Prostaglandins Leukot Essent Fatty Acids , 66 : 467 – 477 .
   PubMed Web of Science ®Google Scholar
• Yang , Y J , Lee , S H , Hong , S J and Chung , B C . 1999 . Comparison of fatty acid profiles in the serum of patients with prostate cancer and benign prostatic hyperplasia . Clin Biochem , 32 : 405 – 409 .
   PubMed Web of Science ®Google Scholar
• Li , L , Ittmann , M , Ayala , G , Tsai , M Amat , O R . 2005 . The emerging role of the PI3-K-Akt pathway in prostate cancer progression . Prostate Cancer Prostatic Dis , 8 : 108 – 118 .
   PubMed Web of Science ®Google Scholar
• Graff , J R , Konicek , B W , McNulty , A M , Wang , Z Houck , K . 2000 . Increased AKT activity contributes to prostate cancer progression by dramatically accelerating prostate tumor growth and diminishing p27Kip1 expression . J Biol Chem , 275 : 24500 – 24505 .
   PubMed Web of Science ®Google Scholar
• Kremer , C L , Klein , R R , Mendelson , J , Browne , W Samadzedeh , L K . 2006 . Expression of mTOR signaling pathway markers in prostate cancer progression . Prostate , 66 : 1203 – 1212 .
   PubMed Web of Science ®Google Scholar
• Hay , N . 2005 . The Akt-mTOR tango and its relevance to cancer . Cancer Cell , 8 : 179 – 183 .
   PubMed Web of Science ®Google Scholar
• Fingar , D C and Blenis , J . 2004 . Target of rapamycin (TOR): an integrator of nutrient and growth factor signals and coordinator of cell growth and cell cycle progression . Oncogene , 23 : 3151 – 3171 .
   PubMed Web of Science ®Google Scholar
• Morgan , T M , Koreckij , T D and Corey , E . 2009 . Targeted therapy for advanced prostate cancer: Inhibition of the PI3K/Akt/mTOR pathway . Curr Cancer Drug Targets , 9 : 237 – 249 .
   PubMed Web of Science ®Google Scholar
• Kinkade , C W , Castillo-Martin , M, , Puzio-Kuter , A , Yan , J Foster , T H . 2008 . Targeting AKT/mTOR and ERK MAPK signaling inhibits hormone-refractory prostate cancer in a preclinical mouse model . J Clin Invest , 118 : 3051 – 3064 .
   PubMed Web of Science ®Google Scholar
• Li , B , Sun , A , Youn , H , Hong , Y Terranova , P F . 2007 . Conditional Akt activation promotes androgen-independent progression of prostate cancer . Carcinogenesis , 28 : 572 – 583 .
   PubMed Web of Science ®Google Scholar
• Shen , M M and Abate-Shen , C . 2007 . Pten inactivation and the emergence of androgen-independent prostate cancer . Cancer Res , 67 : 6535 – 6538 .
   PubMed Web of Science ®Google Scholar
• Dan , H C , Cooper , M J , Cogswell , P C , Duncan , J A Ting , J P . 2008 . Akt-dependent regulation of NF-κB is controlled by mTOR and Raptor in association with IKK . Genes Dev , 22 : 1490 – 1500 .
   PubMed Web of Science ®Google Scholar
• Palayoor , S T , Youmell , M Y , Calderwood , S K , Coleman , C N and Price , B D . 1999 . Constitutive activation of IkB kinase a and NF-kB in prostate cancer cells is inhibited by ibuprofen . Oncogene , 18 : 7389 – 7394 .
   PubMed Web of Science ®Google Scholar
• Kikuchi , E , Horiguchi , Y , Nakashima , J , Kuroda , K Oya , M . 2003 . Suppression of hormone-refractory prostate cancer by a novel nuclear factor κB inhibitor in nude mice . Cancer Res , 63 : 107 – 110 .
   PubMed Web of Science ®Google Scholar
• Cavazos , D A , Price , R S , Apte , S S and Degraffenried , L A . 2011 . Docosahexaenoic acid selectively induces human prostate cancer cell sensitivity to oxidative stress through modulation of NF-kB . Prostate , 71 : 1420 – 1428 .
   PubMed Web of Science ®Google Scholar
• Drobnjak , M , Osman , I , Scher , H I , Fazzari , M Cordon-Cardo , C . 2000 . Overexpression of cyclin D1 Is associated with metastatic prostate cancer to bone . Clin Cancer Res , 6 : 1891 – 1895 .
   PubMed Web of Science ®Google Scholar
• Fu , M , Wang , C , Li , Z , Sakamaki , T and Pestell , R G . 2004 . Minireview: cyclin D1: normal and abnormal functions . Endocrinology , 145 : 5439 – 5447 .
   PubMed Web of Science ®Google Scholar
• Alao , J P . 2007 . The regulation of cyclin D1 degradation: roles in cancer development and the potential for therapeutic invention . Mol Cancer , 6 : 24
   PubMed Web of Science ®Google Scholar
• Chen , Y , Martinez , L A , LaCava , M , Coghlan , L and Conti , C J . 1998 . Increased cell growth and tumorigenicity in human prostate LNCaP cells by overexpression to cyclin D1 . Oncogene , 16 : 1913 – 1920 .
   PubMed Web of Science ®Google Scholar
• He , Y , Franco , O E , Jiang , M , Williams , K Love , HD . 2007 . Tissue-specific consequences of cyclin D1 overexpression in prostate cancer progression . Cancer Res , 67 : 8188 – 8197 .
   PubMed Web of Science ®Google Scholar
• Scher , H I , Steineck , G and Kelly , W K . 1995 . Hormone-refractory (D3) prostate cancer: refining the concept . Urology , 46 : 142 – 148 .
   PubMed Web of Science ®Google Scholar
• Armstrong , A J , Garrett-Mayer , E , de Wit , R , Tannock , I and Eisenberger , M . 2010 . Prediction of survival following first-line chemotherapy in men with castration-resistant metastatic prostate cancer . Clin Cancer Res , 16 : 203 – 211 .
   PubMed Web of Science ®Google Scholar
• Moul , J W and Dawson , N . 2012 . Quality of life associated with treatment of castration-resistant prostate cancer: a review of the literature . Cancer Invest , 30 : 1 – 12 .
   PubMed Web of Science ®Google Scholar
• Chang , S S . 2007 . Treatment options for hormone-refractory prostate cancer . Rev Urol , 9 ( 2 ) : S13 – S18 . Suppl
   PubMedGoogle Scholar
• Pardini , R S . 2006 . Nutritional intervention with omega-3 fatty acids enhances tumor response to anti-neoplastic agents . Chem Biol Interact , 162 : 89 – 105 .
   PubMed Web of Science ®Google Scholar